| Description |
Recombinant Human EGFL7 Protein is expressed from E.coli with His tag at the N-Terminus.It contains Tyr24-Ser273. |
| Purity |
> 95% as determined by Tris-Bis PAGE |
| Accession |
Q9UHF1 |
| Target Symbol |
EGFL7 |
| Synonyms |
EGF-like protein 7; NOTCH4-like protein; VE-statin; NEU1; ZNEU1; EGFL7; MEGF7; MGC111117; RP11-251M1.2 |
| Species |
Human |
| Expression System |
E. coli |
| Tag |
N-His |
| Expression Range |
Tyr24-Ser273 |
| Mol. Weight |
The protein has a predicted MW of 28.4 kDa same as Tris-Bis PAGE result. |
| Form |
Liquid |
| Formulation |
Supplied as 0.22um filtered solution in 4mM HCl (pH 3.0). |
| Endotoxin |
Less than 1EU per ug by the LAL method. |
| Activity |
Immobilized Human EGFL7, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Anti-EGFL7 Antibody, hFc Tag with the EC50 of 17.5ng/ml determined by ELISA. Contact us for detailed testing images. |
| Storage |
Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Shipping |
Shipped with dry ice. |
| Gene Background |
Epidermal growth factor-like domain-containing protein 7 (EGFL7), a member of the epidermal growth factor (EGF)-like protein family, is a potent angiogenic factor expressed in many different cell types. EGFL7 plays a vital role in controlling vascular angiogenesis during embryogenesis, organogenesis, and maintaining skeletal homeostasis. |
